# FDA EIR - AptaPharma Inc. - March 16, 2018

Source: https://www.globalkeysolutions.net/records/eir/aptapharma-inc/1dda210d-9101-42ce-aca7-33184b05f30e

> FDA EIR for AptaPharma Inc. on March 16, 2018. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: AptaPharma Inc.
- Inspection Date: 2018-03-16
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/aptapharma-inc/e2b58c9c-6fd3-44c6-ad1e-7a31d23f561e)

## Related Officers

- [Advisor](https://www.globalkeysolutions.net/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
- [company_representative](https://www.globalkeysolutions.net/people/rakesh-lad/d0792d2d-8d57-4397-ac03-34446ccf9523)
- [recipient](https://www.globalkeysolutions.net/people/siva-rama-krishna-nutalapati/dfbe6394-e9cb-4ea6-a881-119e09c6ca37)
- [company_representative](https://www.globalkeysolutions.net/people/yogesh-desai/e4018e73-151c-42d5-bb89-c7cbc1050206)

Company: https://www.globalkeysolutions.net/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c